Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Arena Pharmaceuticals is 'Strong Hold'. Macroaxis provides Arena Pharmaceuticals buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ARNA positions. The advice algorithm takes into account all of Arena Pharmaceuticals available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ARNA buy-and-hold prospective. Check also Arena Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon Arena Pharmaceuticals has a risk adjusted performance of 0.1078, jensen alpha of 0.1349, total risk alpha of (0.15), sortino ratio of 0.0751 and treynor ratio of 0.2793Macroaxis provides unbiased buy, hold, or sell recommendation on Arena Pharmaceuticals that should be used to complement current analysts and expert consensus on Arena Pharmaceuticals. Our buy or sell advice engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Arena Pharmaceuticals is not overpriced, please confirm all Arena Pharmaceuticals fundamentals including its Current Valuation, Price to Book, Cash and Equivalents, as well as the relationship between Shares Owned by Institutions and Gross Profit . Given that Arena Pharmaceuticals has Number of Shares Shorted of 3.28M, we suggest you validate Arena Pharmaceuticals market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Arena Pharmaceuticals Trading Alerts and Improvement Suggestions
Over 85.0% of the company shares are held by institutions such as insurance companies
Arena Pharmaceuticals has relatively low volatility with skewness of 0.16 and kurtosis of -0.22. However, we advise all investors to independently investigate Arena Pharmaceuticals to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.